I’m trying to make a realistic case to our finance team about total cost of ownership for our BPM setup, and I keep getting conflicting numbers.
Everyone quotes Camunda licensing costs, but from where I’m sitting, the licensing is almost a rounding error compared to what we actually spend on developers building and maintaining workflows. We have three full-time engineers who are essentially Camunda-focused, and that’s a $300K+ annual commitment right there. Plus all the consulting and integration work we’ve had to bring in.
I’ve seen TCO breakdowns that suggest licensing is the dominant cost, but that doesn’t match our actual spending. When I dig into our accounting, developer time is eating about 70 to 75 percent of what we’re spending on Camunda as a platform.
Has anyone else tried to break down their actual TCO and found similar ratios? I want to understand if the high developer costs are just an issue with how complex our workflows are, or if this is typical. And more importantly—if you’ve moved toward platforms that have faster workflow setup times, did that actually move the needle on total costs, or does the time savings just get eaten up by other things?
Your breakdown matches what we found when we actually audited our spending. Licensing was maybe 20 to 25 percent of real TCO. The rest was developer time, which included building workflows, maintaining them, handling integrations, and supporting the platform.
The shift for us came when we started using tools that had faster workflow creation. We went from needing two dedicated engineers to one person who could handle most workflow maintenance. That freed up the other engineer for actual business logic instead of configuration work.
Licensing wasn’t the bottleneck. Developer productivity was. Once we started using something with better tooling for rapid workflow creation, the math changed significantly. Not because the licensing got cheaper, but because we needed fewer people managing it.
When we did our TCO analysis, we broke it down by actual spend, and you’re right—licensing was only about 20 percent of the total. Two developers maintaining workflows, plus the time spent on each new integration, added up much faster. The thing that actually moved the needle was reducing time-to-deployment for new workflows. When setup and testing took weeks, you were essentially carrying developer costs across the entire project timeline. We reduced that to days by improving our workflow tooling.
Enterprise BPM TCO typically breaks down as approximately 25 to 30 percent licensing and 70 to 75 percent personnel and implementation costs. Your ratio matches industry standards. The leverage point isn’t negotiating license fees—it’s reducing time to value and maintenance overhead. Platforms that support rapid workflow creation and have better visual builders can reduce developer time requirements by 40 to 50 percent. That directly impacts the larger cost component. If you’re spending $300K annually on developers for Camunda workflows, a 40 percent reduction in development cycles could save you $120K per year even if licensing stays constant.
Our TCO: licensing ~20%, dev costs ~70%. Real savings come from faster workflow building, not cheaper licenses. Worth investigating tools that speed up dev time.
When we analyzed our BPM spending, licensing was barely significant. The real weight was developer time—roughly matching your 70 to 75 percent figure.
We had two engineers effectively tied up maintaining and building workflows. The bottleneck wasn’t Camunda licensing flexibility. It was how long it took to turn a business requirement into something deployed.
We shifted to a platform with visual workflow building and faster iteration. That’s where the economics changed. Same licensing cost ballpark, but we reduced the time to deploy new workflows from weeks to days. One engineer could now do what two were doing before.
The leverage isn’t in the licensing line item. It’s in reducing the developer time component by improving your workflow creation tools. That’s where the real TCO savings live.